Skip to content
buyModerate

Srinivas Akkaraju bought $11M of ALMS

director at ALUMIS INC.. 986,721 shares at an average of $10.87, traded Sep 4, 2026, filed Sep 9, 2026.

Conviction score
46
Value
$11M
986,721 shares
Holdings after
2,298,783
+22% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $10.7M at market
    +25
  • Relative to holdings
    Holdings up 22%
    +6
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ALMSOct 9, 2026 · close 7.16
Since filing Sep 9, 2026: -26.9%SPY +2.4% · excess -29.3%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001231919-26-001158, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 4, 2026POpen-market purchase
Common Stockindirect: By Samsara BioCapital, L.P.
+220,070$11.17$2.5M4,711,80133 d ago
Sep 4, 2026POpen-market purchase
Common Stockindirect: By Samsara Opportunity Fund, L.P.
+220,070$11.17$2.5M2,073,55833 d ago
Sep 8, 2026SOpen-market sale
Common Stockindirect: By Samsara BioCapital, L.P.
-48,066$10.55$507k4,663,73533 d ago
Sep 8, 2026SOpen-market sale
Common Stockindirect: By Samsara Opportunity Fund, L.P.
-48,065$10.55$507k2,025,49333 d ago
Sep 8, 2026POpen-market purchase
Common Stockindirect: By Samsara BioCapital, L.P.
+273,291$10.63$2.9M4,937,02633 d ago
Sep 8, 2026POpen-market purchase
Common Stockindirect: By Samsara Opportunity Fund, L.P.
+273,290$10.63$2.9M2,298,78333 d ago

Related signals

Other insiders at ALUMIS INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
40Moderate
ALMSsell
ALUMIS INC.
Srinivas Akkaraju
director
$1.0M
96,131 shares
-2%
66Notable
ALMSbuy 4
ALUMIS INC.
Srinivas Akkaraju
director
$1.5M
320,290 shares
+10%
42Moderate
ALMSbuy 4
ALUMIS INC.
Foresite Capital Management VI LLC
owner
$202k
45,000 shares
+1%
42Moderate
ALMSbuy 4
ALUMIS INC.
Foresite Labs, LLC
owner
$202k
45,000 shares
+1%
50Moderate
ALMSbuy 4
ALUMIS INC.
James B. Tananbaum
director, owner
$202k
45,000 shares
+1%
54Moderate
ALMSbuy 2
ALUMIS INC.
Martin Babler
President, CEO and Chairman
$101k
15,650 shares
+17%
50Moderate
ALMSbuy 2
ALUMIS INC.
Alan Colowick
director
$130k
18,404 shares
-

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Srinivas Akkaraju bought $11M of ALMS | InsiderTell